<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Physiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id><journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id><journal-title-group><journal-title>Frontiers in Physiology</journal-title></journal-title-group><issn pub-type="epub">1664-042X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5808211</article-id><article-id pub-id-type="doi">10.3389/fphys.2018.00065</article-id><article-categories><subj-group subj-group-type="heading"><subject>Physiology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>TNF-&#x003b1; Increases Production of Reactive Oxygen Species through Cdk5 Activation in Nociceptive Neurons</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sandoval</surname><given-names>Rodrigo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/508327/overview"/></contrib><contrib contrib-type="author"><name><surname>Lazcano</surname><given-names>Pablo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/520309/overview"/></contrib><contrib contrib-type="author"><name><surname>Ferrari</surname><given-names>Franco</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/495382/overview"/></contrib><contrib contrib-type="author"><name><surname>Pinto-Pardo</surname><given-names>Nicol&#x000e1;s</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/519842/overview"/></contrib><contrib contrib-type="author"><name><surname>Gonz&#x000e1;lez-Billault</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/13510/overview"/></contrib><contrib contrib-type="author"><name><surname>Utreras</surname><given-names>El&#x000ed;as</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="author-notes" rid="fn002"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/418697/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Laboratory of Molecular and Cellular Mechanisms of Pain, Department of Biology, Faculty of Science, Universidad de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff><aff id="aff2"><sup>2</sup><institution>Doctorate in Biomedicine, Universidad de los Andes</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff><aff id="aff3"><sup>3</sup><institution>Laboratory of Cellular and Neuronal Dynamics, Department of Biology, Faculty of Science, Universidad de Chile</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff><aff id="aff4"><sup>4</sup><institution>Center for Geroscience, Brain Health and Metabolism (GERO)</institution>, <addr-line>Santiago</addr-line>, <country>Chile</country></aff><aff id="aff5"><sup>5</sup><institution>The Buck Institute for Research on Aging</institution>, <addr-line>Novato, CA</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Mustafa Naziroglu, S&#x000fc;leyman Demirel University, Turkey</p></fn><fn fn-type="edited-by"><p>Reviewed by: Maria Marino, Universit&#x000e0; degli Studi Roma Tre, Italy; Felipe Simon, Universidad Andr&#x000e9;s Bello, Chile; Laszlo Pecze, University of Fribourg, Switzerland</p></fn><corresp id="fn001">*Correspondence: Christian Gonz&#x000e1;lez-Billault <email xlink:type="simple">chrgonza@uchile.cl</email></corresp><corresp id="fn002">El&#x000ed;as Utreras <email xlink:type="simple">elias.utreras@uchile.cl</email></corresp><fn fn-type="other" id="fn003"><p>This article was submitted to Membrane Physiology and Membrane Biophysics, a section of the journal Frontiers in Physiology</p></fn></author-notes><pub-date pub-type="epub"><day>06</day><month>2</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>65</elocation-id><history><date date-type="received"><day>06</day><month>11</month><year>2017</year></date><date date-type="accepted"><day>18</day><month>1</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Sandoval, Lazcano, Ferrari, Pinto-Pardo, Gonz&#x000e1;lez-Billault and Utreras.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Sandoval, Lazcano, Ferrari, Pinto-Pardo, Gonz&#x000e1;lez-Billault and Utreras</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>The participation of reactive oxygen species (ROS) generated by NOX1 and NOX2/NADPH oxidase has been documented during inflammatory pain. However, the molecular mechanism involved in their activation is not fully understood. We reported earlier a key role of Cyclin-dependent kinase 5 (Cdk5) during inflammatory pain. In particular, we demonstrated that TNF-&#x003b1; increased p35 expression, a Cdk5 activator, causing Cdk5-mediated TRPV1 phosphorylation followed by an increment in Ca<sup>2+</sup> influx in nociceptive neurons and increased pain sensation. Here we evaluated if Cdk5 activation mediated by p35 transfection in HEK293 cells or by TNF-&#x003b1; treatment in primary culture of nociceptive neurons could increase ROS production. By immunofluorescence we detected the expression of catalytic subunit (Nox1 and Nox2) and their cytosolic regulators (NOXO1 and p47<sup>phox</sup>) of NOX1 and NOX2/NADPH oxidase complexes, and their co-localization with Cdk5/p35 in HEK293 cells and in nociceptive neurons. By using a hydrogen peroxide sensor, we detected a significant increase of ROS production in p35 transfected HEK293 cells as compared with control cells. This effect was significantly blocked by VAS2870 (NADPH oxidase inhibitor) or by roscovitine (Cdk5 activity inhibitor). Also by using another ROS probe named DCFH-DA, we found a significant increase of ROS production in nociceptive neurons treated with TNF-&#x003b1; and this effect was also blocked by VAS2870 or by roscovitine treatment. Interestingly, TNF-&#x003b1; increased immunodetection of p35 protein and NOX1 and NOX2/NADPH oxidase complexes in primary culture of trigeminal ganglia neurons. Finally, the cytosolic regulator NOXO1 was significantly translocated to plasma membrane after TNF-&#x003b1; treatment and roscovitine blocked this effect. Altogether these results suggest that Cdk5 activation is implicated in the ROS production by NOX1 and NOX2/NADPH oxidase complexes during inflammatory pain.</p></abstract><kwd-group><kwd>Cdk5</kwd><kwd>NOX</kwd><kwd>TNF-&#x003b1;</kwd><kwd>pain signaling</kwd><kwd>ROS</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Fondo Nacional de Desarrollo Cient&#x000ed;fico y Tecnol&#x000f3;gico<named-content content-type="fundref-id">10.13039/501100002850</named-content></funding-source><award-id rid="cn001">1151043</award-id><award-id rid="cn001">1140325</award-id></award-group></funding-group><counts><fig-count count="7"/><table-count count="0"/><equation-count count="0"/><ref-count count="64"/><page-count count="13"/><word-count count="7504"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>During tissue damage, several inflammatory mediators as tumor necrosis factor-&#x003b1; (TNF-&#x003b1;) are locally released, activating signaling pathways in sensory neurons that increase peripheral sensitization and pain signaling (Khan et al., <xref rid="B28" ref-type="bibr">2008</xref>; Sessle, <xref rid="B50" ref-type="bibr">2011</xref>; Rozas et al., <xref rid="B49" ref-type="bibr">2016</xref>). Activated protein kinases such as PKC, PKA, and Cdk5 are involved in peripheral sensitization through phosphorylation of several ion channels expressed on nociceptive neurons (Basbaum et al., <xref rid="B4" ref-type="bibr">2009</xref>; Rozas et al., <xref rid="B49" ref-type="bibr">2016</xref>; Coddou et al., <xref rid="B10" ref-type="bibr">2017</xref>). Cdk5 is an essential kinase in brain development and function (Dhariwala and Rajadhyaksha, <xref rid="B13" ref-type="bibr">2008</xref>; Utreras et al., <xref rid="B53" ref-type="bibr">2009a</xref>; Contreras-Vallejos et al., <xref rid="B11" ref-type="bibr">2012</xref>). Interestingly, our group reported earlier that Cdk5 plays a crucial role during inflammatory pain signaling (Utreras et al., <xref rid="B53" ref-type="bibr">2009a</xref>, <xref rid="B58" ref-type="bibr">2011</xref>; Prochazkova et al., <xref rid="B48" ref-type="bibr">2013</xref>; Rozas et al., <xref rid="B49" ref-type="bibr">2016</xref>; Coddou et al., <xref rid="B10" ref-type="bibr">2017</xref>). Cdk5 is a proline-directed serine/threonine kinase, mostly active in post-mitotic neurons, where its specific activators p35 and p39 are mainly expressed (Lew et al., <xref rid="B35" ref-type="bibr">1994</xref>; Dhariwala and Rajadhyaksha, <xref rid="B13" ref-type="bibr">2008</xref>; Utreras et al., <xref rid="B56" ref-type="bibr">2009c</xref>). We reported also that cytokines such as TNF-&#x003b1; or TGF-&#x003b2;1 up-regulate p35 expression and Cdk5 kinase activity with a subsequent phosphorylation of transient receptor potential vaniloid 1 (TRPV1) and purinergic P2X2a receptor (P2X2aR), which are important receptors channels involved during inflammatory pain signaling (Utreras et al., <xref rid="B54" ref-type="bibr">2009b</xref>, <xref rid="B58" ref-type="bibr">2011</xref>, <xref rid="B55" ref-type="bibr">2012</xref>, <xref rid="B57" ref-type="bibr">2013</xref>; Prochazkova et al., <xref rid="B48" ref-type="bibr">2013</xref>; Rozas et al., <xref rid="B49" ref-type="bibr">2016</xref>; Coddou et al., <xref rid="B10" ref-type="bibr">2017</xref>).</p><p>On the other hand, reactive oxygen species (ROS) represent important players during inflammation (Mittal et al., <xref rid="B44" ref-type="bibr">2014</xref>). There is growing evidence supporting ROS as molecules that contribute to pain hypersensitivity (Kallenborn-Gerhardt et al., <xref rid="B27" ref-type="bibr">2013</xref>). Interestingly, antioxidant therapy has been used to overcome painful effects developed in inflammatory pain models (Khattab, <xref rid="B29" ref-type="bibr">2006</xref>; Lauro et al., <xref rid="B33" ref-type="bibr">2016</xref>; Wu et al., <xref rid="B61" ref-type="bibr">2017</xref>). There are several enzymatic systems that generate ROS such as lipoxygenases, xanthine oxidases, cyclooxygenases, cytochrome P450 monooxygenases, nitric oxide synthases, and NADPH oxidases (NOX) (Holmstr&#x000f6;m and Finkel, <xref rid="B20" ref-type="bibr">2014</xref>; B&#x000f3;rquez et al., <xref rid="B8" ref-type="bibr">2016</xref>; Wilson et al., <xref rid="B59" ref-type="bibr">2017</xref>). NOX enzymes belong to the NOX family that is composed by seven members (NOX1-5 and Duox 1-2). Interestingly, Nox1, Nox2, and Nox4 catalytic enzymes have been associated with pain signaling (Kallenborn-Gerhardt et al., <xref rid="B26" ref-type="bibr">2012</xref>, <xref rid="B27" ref-type="bibr">2013</xref>, <xref rid="B25" ref-type="bibr">2014</xref>; Geis et al., <xref rid="B19" ref-type="bibr">2017</xref>). NOX enzymes reside at the plasma membrane in tight association with the integral membrane protein p22<sup>phox</sup>. When NOX complex becomes active, it generates ROS by a catalytic transfer of electrons from NADPH to O<sub>2</sub> to form superoxide anion and hydrogen peroxide (Sumimoto et al., <xref rid="B52" ref-type="bibr">2005</xref>). Nox1 activation occurs by PKC-mediated phosphorylation of the cytosolic subunit Nox organizer 1 (NOXO1) allowing NOXO1-p22<sup>phox</sup> interaction (Debbabi et al., <xref rid="B12" ref-type="bibr">2013</xref>). Similarly, activation of Nox2 (Gp91<sup>phox</sup>) needs the recruitment of the regulatory cytosolic subunits p47<sup>phox</sup>, p67<sup>phox</sup>, and Rac1 (El-Benna et al., <xref rid="B16" ref-type="bibr">2008</xref>). Multiple serine phosphorylation of p47<sup>phox</sup> by PKC is a key step that induces association with p22<sup>phox</sup> at the plasma membrane and activation of the complex (Fontayne et al., <xref rid="B17" ref-type="bibr">2002</xref>; Meijles et al., <xref rid="B43" ref-type="bibr">2014</xref>). In the present work we describe a new role of Cdk5 in the modulation of redox balance in nociceptive neurons. Thus, activation of Cdk5 in HEK293 cells and primary sensory neurons was related to increased ROS production. Interestingly, this effect was blocked by inhibition of NOX complex or Cdk5 kinase activity, suggesting a molecular link between Cdk5 and NOX-mediated ROS production. Implications of these findings could address additional roles of Cdk5 in pain signaling.</p></sec><sec sec-type="materials and methods" id="s2"><title>Materials and methods</title><sec><title>Transfection of HEK293 cells</title><p>HEK293 cells (ATCC#CRL-1573) were grown in Dulbecco Modified Eagle Medium (DMEM) containing 10% of fetal bovine serum (FBS) and penicillin/streptomycin (100 mg/mL) (Invitrogen, Carlsbad CA). HEK293 cells were transiently co-transfected with mouse CMV-p35 (Coddou et al., <xref rid="B10" ref-type="bibr">2017</xref>) and HyPer constructs (Evrogen, Moscow, Russia) by using Lipofectamine 2000 reagent (Invitrogen, Carlsbad CA) and treated with roscovitine (30 &#x003bc;M, Sigma-Aldrich, Saint Louis, MO) or VAS2870 (1 &#x003bc;M, Calbiochem, CA USA) during 24 h and 1 h, respectively.</p></sec><sec><title>Primary culture of mouse nociceptive neurons</title><p>Nociceptive neurons were cultured as described previously (Coddou et al., <xref rid="B10" ref-type="bibr">2017</xref>). Briefly, trigeminal ganglia (TG) and dorsal root ganglia (DRG) were dissected out from 7 to 10 month-old C57/FVB mice and incubated with collagenase XI (0.66 mg/mL) and dispase II (3 mg/mL, Sigma-Aldrich, Saint Louis, MO) in an INCmix solution (NaCl 155 mM; K<sub>2</sub>HPO<sub>4</sub> 1.5 mM; HEPES 10 mM; glucose 5 mM; at pH 7.4). Enzymatic digestion was performed for 45 min at 37&#x000b0;C in 5% CO<sub>2</sub>, and consecutively treated with DNase I (100 &#x003bc;g/mL, Roche Diagnostic, Indianapolis, IN) during 10 min at 37&#x000b0;C. TG/DRG cell suspensions were separated over discontinuous 28&#x02013;12.5% Percoll gradients (GE Healthcare). Isolated cells were cultured in minimum essential media (MEM) supplemented with 10% FBS, penicillin/streptomycin (100 mg/mL), and MEM-Vit (Invitrogen, Carlsbad CA). Cells were plated on 12-mm poly-L-lysine-coated glass coverslips and cultured for 2 days <italic>in vitro</italic> (2DIV). To evaluate the involvement of Cdk5 activation by TNF-&#x003b1; and NOX signaling, TG and DRG primary cultures (2DIV) were treated with TNF-&#x003b1; (25&#x02013;50 ng/mL, Sigma-Aldrich, Saint Louis, MO) in the presence or absence of roscovitine (20 &#x003bc;M) or VAS2870 (1 &#x003bc;M) during 24 h and 1 h, respectively. Animal experiments were conducted in accordance with the principles and procedures of the Ethics Committee of the Biology Department, Faculty of Sciences, Universidad de Chile, Santiago, Chile.</p></sec><sec><title>Immunofluorescence assays</title><p>HEK293 cells transfected with p35 or primary cultures of TG and DRG neurons were washed with warm PBS for 5 min and fixed with a 4% PFA-4% sucrose solution in PBS at 37&#x000b0;C for 20 min. Cells were washed and permeabilized for 5 min with 0.2% Triton X-100-PBS solution. After washout with PBS, cells were blocked with a 5% BSA solution in PBS at room temperature for 1 h. Primary antibodies were used at following concentrations: anti-Cdk5 mouse DC17 (1:100), anti-p35 rabbit C19 (1:100), anti-Nox1 goat sc-292094 (1:100), anti-NOXO1 rabbit sc-5821 (1:100), anti-NOXA1 rabbit sc-160597-R (1:100), anti-p47<sup>phox</sup> rabbit sc-14015 (1:100), anti-MAP1B goat N-19 (1:200), anti-p35 goat A-18 (1:100) (from Santa Cruz Biotechnology); anti-gp91<sup>phox</sup> mouse ab109366 (1:100), and anti-p22<sup>phox</sup> rabbit ab75941 (1:100) (from Abcam); anti-&#x003b2;III tubulin mouse clone G7121 (1:1000) (from Promega); p35 rabbit C64B10 (1:100) (from Cell Signaling Technology, Denver, USA). All primary antibodies were diluted in 1% BSA solution and incubated overnight at 4&#x000b0;C. The coverslips were washed with PBS and then incubated with corresponding Alexa Fluor-conjugated secondary antibodies. We used the following secondary antibodies:-Donkey anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488 #A21202-Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 488 #A21206-Donkey anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 546 #A10040-Donkey anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 546 #A10036-Donkey anti-Goat IgG (H+L) Cross-Adsorbed Secondary Antibody, Alexa Fluor 633 #A21082 (Molecular Probes, Life Technologies, Grand Island, NY) in combination with Dapi (Thermo Fisher Scientific) for 1 h at room temperature. Finally, coverslips were washed with PBS and mounted on a slide with FluorSave (Calbiochem). Images were acquired using confocal microscopy (LSM 710 Meta Model, Carl Zeiss Microscopy) and processed with the LSM Image Browser (Carl Zeiss Microscopy) software.</p></sec><sec><title>Immunofluorescence quantification analysis</title><p>As an estimation of protein amount in individual neurons, the fluorescence intensity was quantified as reported earlier (McCloy et al., <xref rid="B42" ref-type="bibr">2014</xref>). Confocal images (40X) acquired from immunofluorescences were processed by using ImageJ 1.46r software (NIH, Bethesda, MD) and individual ROIs were assigned to each neuron and integrated density was obtained for each fluorescent emission.</p></sec><sec><title>Hydrogen peroxide measurement in transfected HEK293 cells</title><p>We evaluated hydrogen peroxide content in HEK293 cells by using HyPer sensor as previously reported (Belousov et al., <xref rid="B5" ref-type="bibr">2006</xref>). HEK293 cells co-transfected with HyPer and CMV-p35 plasmids during 24 h were fixed in 4% paraformaldehyde/4% sucrose solution in PBS. Then, cells were excited at 488 and 405 nm and emission was collected at 505&#x02013;530 nm in a confocal microscopy (LSM 710 Meta Model, Carl Zeiss Microscopy). Fluorescence emission from excitation at 488 nm was divided by fluorescence emission at 405 nm excitation (488:405) as a measure of the hydrogen peroxide content (Belousov et al., <xref rid="B5" ref-type="bibr">2006</xref>).</p></sec><sec><title>Neuronal ROS measurement</title><p>To evaluate intracellular ROS levels, primary cultures of mouse TG and DRG neurons were incubated simultaneously with CellTracker<sup>TM</sup> Orange dye (CMTMR 1 &#x003bc;M, Thermo Fisher Scientific) and 2&#x02032;,7&#x02032;-Dichlorofluorescin diacetate (DCFH-DA 1 &#x003bc;M, Sigma) for 20 min at 37&#x000b0;C similarly to previously reported (Wilson et al., <xref rid="B60" ref-type="bibr">2015</xref>). DCFH-DA detects intracellular oxidative species by increasing fluorescence emission after oxidation (Lebel and Bondy, <xref rid="B34" ref-type="bibr">1990</xref>). Sensory neurons were fixed and mounted to measure the fluorescence by excitation at 488 nm and emission acquisition at 505&#x02013;530 nm. Fluorescence from CMTMR dye incorporated in neurons was used to normalize DCFH-DA emission, and was acquired by excitation at 543 nm and emission acquisition at 548&#x02013;679 nm.</p></sec><sec><title>Translocation to plasma membrane analysis</title><p>To estimate plasma membrane translocation of NOX cytosolic subunits (NOXO1 and p47<sup>phox</sup>), we drew a line that crosses the 2D surface of each neuron from end to end (<bold>Figure 6A</bold>). Gray value was obtained along the drawn line to estimate the amount of protein in zones near and far of plasma membrane (peripheral and centric areas, respectively). Mean gray value of centric areas were calculated as the mean of all gray values comprising the medial portion of the drawn line (30% of total line). Peripheral areas were defined as the first 4 &#x003bc;m from the periphery to the center in the drawn line. Mean gray value was calculated in this short section alike centric areas. Finally, the mean gray value of peripheral area (two per neuron) was normalized to corresponding centric area mean gray value (<bold>Figure 6A</bold>).</p></sec><sec><title>Western blot analysis</title><p>Protein extracts from HEK293 cells transfected with p35 were obtained in T-PER buffer (Pierce, Rockford, IL) with Complete Mini protease inhibitor cocktail tablets and PhosSTOP phosphatase inhibitor cocktail tablets (Roche Diagnostic, Indianapolis, IN). Protein extracts were resolved in 12% SDS-PAGE gels and transferred to nitrocellulose membranes (Invitrogen, Carlsbad, CA). Membranes were soaked in blocking buffer (5% non-fat dry milk in Tris-Buffered Saline (TBS) with 0.05% Tween-20 (TBS-T)) for 1 h at room temperature, and then incubated overnight at 4&#x000b0;C, with primary antibody diluted in 1% non-fat dry milk blocking buffer. The membranes were washed in TBS-T and incubated for 1 h at room temperature with the secondary antibodies diluted in 1% non-fat dry milk blocking buffer. Immunoreactivity was detected by using Super-Signal West Pico Chemiluminescent Substrate (Thermo Scientific, Rockford, IL). Western blots were performed by using anti-p35 rabbit C19 (1:250) and anti-Cdk5 mouse DC17 (1:500) from Santa Cruz Biotechniology; anti-&#x003b1;-tubulin mouse (1:10.000) from Sigma. We used secondary antibodies anti-mouse and anti-rabbit coupled to Horseradish Peroxidase from Santa Cruz Biothecnology. The optical densities of the bands were quantified using an image analysis system with ImageJ 1.46r software (NIH, Bethesda, MD).</p></sec><sec><title>Statistical analysis</title><p>All experiments were performed a minimum of three times. All graphs show the mean &#x000b1; <italic>SD</italic>. Statistical evaluation was performed with GraphPad Prism software, version 6.1 (GraphPad, San Diego, CA). Significant differences between experiments were assessed by an unpaired <italic>t</italic>-test or a one-way analysis of variance with a Bonferroni's multiple comparison test, where &#x003b1; was set to 0.05.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><sec><title>Endogenous expression of NOX complexes in HEK293 cells</title><p>To establish Cdk5 participation in NOX1 and NOX2-dependent ROS production, we analyzed the immunolocalization of NOX1 and NOX2/NADPH oxidase complexes in HEK293 cells transfected with p35 that endogenously express Cdk5 (Figure <xref ref-type="fig" rid="F1">1</xref>). By immunofluorescence we detected co-localization of catalytic (Nox1 and Nox2) and cytosolic subunits (NOXO1 and p47<sup>phox</sup>) with p35 protein. We observed endogenous expression of Nox1, Nox2, NOXO1 and p47<sup>phox</sup> in plasma membrane and in cytoplasmic regions of HEK293 cells (Figures <xref ref-type="fig" rid="F1">1A&#x02013;D</xref>, green label). We also found that HEK293 cells expressed other members of the catalytic NOX core such as p22<sup>phox</sup> and NOXA1 (data not shown). Most important, we immunodetected p35 in some transfected cells co-localizing with NOX1 and NOX2 complexes (Figures <xref ref-type="fig" rid="F1">1A&#x02013;D</xref>, red label). Additionally, we detected endogenous Cdk5 and transfected p35 proteins by Western blot from HEK293 cells in the presence or absence of roscovitine (Figure <xref ref-type="fig" rid="F2">2A</xref>). We also confirmed that HEK293 cells transfected with p35 have increased Cdk5 kinase activity (data not shown), similarly as previously reported (Zheng et al., <xref rid="B64" ref-type="bibr">2002</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Endogenous expression of Nox1/NOXO1 and Nox2/p47<sup>phox</sup> in HEK293 cells transfected with p35 plasmid<bold>. (A,C)</bold> Representative immunofluorescences showing catalytic subunits Nox1 and Nox2 (in green, respectively) co-localizing with p35 (in red) in transfected HEK293 cells. <bold>(B,D)</bold> Representative immunofluorescences of regulatory subunits NOXO1 and p47<sup>phox</sup> (in green, respectively) co-localizing with p35 (in red) in transfected HEK293 cells. Inset for each figure showing staining by separate in larger magnification. DAPI for nuclear staining (gray). Scale bars are 20 and 5 &#x003bc;m insets.</p></caption><graphic xlink:href="fphys-09-00065-g0001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Increased Cdk5 kinase activity in HEK293 cells transfected with p35 produced elevated hydrogen peroxide content measured by HyPer probe. <bold>(A)</bold> Western blot analysis against p35, Cdk5, and &#x003b1;-tubulin from HEK293 cells untransfected (UT), transfected with p35 (p35), and transfected with p35 and treated with roscovitine (30 &#x003bc;M) (p35 + Rosc) during 24 h. <bold>(B)</bold> Representative immunofluorescences of p35 (left) and HyPer 480/405 ratio (right) from HEK293 cells transfected with p35 and HyPer, treated with roscovitine or VAS2870. Thermal scale: increased hydrogen peroxide content toward red. <bold>(C)</bold> Normalized HyPer 480/405 ratio in same conditions of <bold>(B)</bold>. Scale bars are 20 &#x003bc;m. The bar graphs represent mean &#x000b1; SD of <italic>n</italic> = 4&#x02013;7 different cell cultures. Number of cells analyzed is showed inside each column. Statistical differences correspond to a one-way ANOVA with a Bonferroni's multiple comparison test.</p></caption><graphic xlink:href="fphys-09-00065-g0002"/></fig></sec><sec><title>Increased cdk5-dependent ROS production in HEK293 cells</title><p>To evaluate if ROS production is affected by increased Cdk5 activity in transfected HEK293 cells, we used the genetically encoded biosensor HyPer which detects intracellular production of hydrogen peroxide (Lukyanov and Belousov, <xref rid="B41" ref-type="bibr">2014</xref>; Wilson et al., <xref rid="B60" ref-type="bibr">2015</xref>). Firstly, by immunofluorescence we determined p35 expression in HEK293 cells co-transfected with p35 and HyPer plasmids (Figure <xref ref-type="fig" rid="F2">2B</xref>). Then, we generated a HyPer map (480/405 nm ratio) for each treatment condition of HEK293 cells. In HEK293 cells overexpressing p35 we found a significant increase of hydrogen peroxide content and this effect was significantly reverted by roscovitine (Figures <xref ref-type="fig" rid="F2">2B,C</xref>). Interestingly, Cdk5-dependent ROS production was also reverted by NOX inhibitor, VAS2870 (Figures <xref ref-type="fig" rid="F2">2B,C</xref>), suggesting that NOX complexes represent a source for the elevated ROS observed in this model. The basal hydrogen peroxide production was not affected by roscovitine treatment and only slightly reduced by VAS2870 treatment (Figures <xref ref-type="fig" rid="F2">2B,C</xref>). These results suggest that production of ROS is dependent, in part, on Cdk5 activity in HEK293 cells expressing active NOX1 and NOX2 complexes.</p></sec><sec><title>Endogenous expression of NOX1 and NOX2 complexes and Cdk5/p35 in primary culture of TG neurons</title><p>Our previous data suggests that Cdk5 is involved in ROS production mediated by the NOX1 and NOX2 complex in HEK293 cells. Importantly, the production of ROS (Kallenborn-Gerhardt et al., <xref rid="B27" ref-type="bibr">2013</xref>) and also Cdk5 kinase (Utreras et al., <xref rid="B53" ref-type="bibr">2009a</xref>) are active participants during pain signaling. Therefore, we evaluated the co-distribution of Cdk5/p35 with members of NOX1 and NOX2 complexes in sensory neurons. The NOX family members NOX1 and NOX2 have been associated with pain processes (Kallenborn-Gerhardt et al., <xref rid="B27" ref-type="bibr">2013</xref>), consequently we studied their distribution in primary culture of mouse TG neurons. By immunofluorescence, we identified that NOX members of both complexes are highly expressed in neurons of all sizes (small, medium, and large neurons), respect to non-neuronal cells (Figure <xref ref-type="fig" rid="F3">3</xref>, negative cells for &#x003b2;III-tubulin). Catalytic (Nox1 and Nox2) and cytoplasmic (NOXO1 and p47<sup>phox</sup>) subunits were mostly found in somata and in neurites, with the exception of NOXO1, which was equally identified in both neuronal regions including large processes (Figures <xref ref-type="fig" rid="F3">3A&#x02013;H</xref>). We also observed endogenous Cdk5 and p35 expression in TG neurons and others cells co-localizing with both NOX1/NOX2 complexes (Figures <xref ref-type="fig" rid="F3">3A&#x02013;H</xref>), suggesting that Cdk5-dependent ROS production is likely to occur in trigeminal ganglia neurons.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Endogenous expression of NOX1 and NOX2 complexes with Cdk5/p35 in primary culture of trigeminal ganglia neurons. Representative immunofluorescences of catalytic subunit Nox1 <bold>(A,B)</bold> and its regulatory subunit NOXO1 <bold>(C)</bold> and NOXA1 <bold>(D)</bold> in red, co-localizing with Cdk5 and p35 (in green) expressed endogenously in primary culture of trigeminal ganglia neurons. Representative immunofluorescences of catalytic subunit Nox2 <bold>(E)</bold> and its regulatory subunits p47<sup>phox</sup>
<bold>(F,H)</bold> and p22<sup>phox</sup>
<bold>(G)</bold> in red, co-localizing with Cdk5 and p35 (in green) expressed endogenously in primary culture of trigeminal ganglia neurons. &#x003b2;III-tubulin or MAP1B is a marker of neurons (gray). Scale bars are 50 or 10 &#x003bc;m (insets).</p></caption><graphic xlink:href="fphys-09-00065-g0003"/></fig></sec><sec><title>TNF-&#x003b1; increased ROS production in primary culture of TG and DRG neurons</title><p>Previously, we reported that TNF-&#x003b1; increases Cdk5 kinase activity by transcriptional up-regulation of p35 in cell lines and in TG and DRG neurons (Utreras et al., <xref rid="B54" ref-type="bibr">2009b</xref>; Rozas et al., <xref rid="B49" ref-type="bibr">2016</xref>). To evaluate the association between TNF-&#x003b1;-mediated Cdk5 activation and NOX-dependent ROS production in nociceptive neurons, we performed primary cultures of mouse TG and DRG neurons treated with TNF-&#x003b1; and we further measured ROS production by using DCFH-DA probe (Lebel and Bondy, <xref rid="B34" ref-type="bibr">1990</xref>; Wilson et al., <xref rid="B60" ref-type="bibr">2015</xref>) (Figures <xref ref-type="fig" rid="F4">4A,B</xref>). We found that TNF-&#x003b1; treatment significantly increased the intracellular ROS content. In contrast, this effect was completely blocked by roscovitine, suggesting the involvement of Cdk5 in ROS production in sensory neurons (Figures <xref ref-type="fig" rid="F4">4A&#x02013;D</xref>). Interestingly, we found that the source of ROS content in TG and DRG primary culture was NOX-dependent, since VAS2870 also blocked the TNF-&#x003b1;-mediated ROS production (Figures <xref ref-type="fig" rid="F4">4A&#x02013;D</xref>). Basal ROS production was not affected by roscovitine treatment and only slightly reduced by VAS2870 in DRG neurons. These data are in agreement with our previous results obtained in HEK293 cells, suggesting that Cdk5 contributes to ROS balance in nociceptive neurons. However, the molecular mechanism involving Cdk5 activity in ROS production through NOX complexes is not clear.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>TNF-&#x003b1; increases ROS production in primary culture of mouse TG and DRG neurons. Representative images of primary cultures loaded with DCFH-DA (DCF) and CMTMR (CT) probes from TG <bold>(A)</bold> and DRG <bold>(B)</bold> neurons treated with TNF-&#x003b1; alone or with roscovitine or VAS2870. <bold>(C,D)</bold> Quantification of fluorescence intensity of DCF normalized by CT under each corresponding treatment in TG neurons <bold>(C)</bold> or DRG neurons <bold>(D)</bold>. Scale bars are 20 &#x003bc;m. The bar graphs represent mean &#x000b1; <italic>SD</italic> of <italic>n</italic> = 3 different experiments. Statistical differences correspond to a one-way ANOVA with a a Bonferroni's multiple comparison test. Number of analyzed neurons for each treatment is inside the corresponding bar.</p></caption><graphic xlink:href="fphys-09-00065-g0004"/></fig></sec><sec><title>TNF-&#x003b1; increased expression of NOX1 and NOX2 members in primary culture of mouse TG neurons</title><p>Because TNF-&#x003b1; increased ROS production in nociceptive neurons, presumably by NOX/NADPH oxidase increased activation, we analyzed the catalytic and cytoplasmic subunits of NOX1 and NOX2 complexes in primary TG cultures treated with TNF-&#x003b1; by immunofluorescence. First, we confirmed that TNF-&#x003b1; increased p35 immunodetection in primary culture of TG neurons (Figures <xref ref-type="fig" rid="F5">5A,B</xref>) similarly as previously reported (Rozas et al., <xref rid="B49" ref-type="bibr">2016</xref>). We also found that TNF-&#x003b1; treatment increased immunodetection of Nox1, NOXO1, Nox2, and p47<sup>phox</sup> in TG neurons. Interestingly, roscovitine treatment significantly blocked TNF-&#x003b1; effect in the immunodetection of Nox1 in cultured TG neurons. On the other hand, immunodetection of NOXO1, Nox2, and p47<sup>phox</sup> was not affected by roscovitine treatment (Figures <xref ref-type="fig" rid="F5">5C&#x02013;G</xref>).</p><fig id="F5" position="float"><label>Figure 5</label><caption><p>TNF-&#x003b1; treatment increases p35, Nox1 and Nox2 expression in primary culture of mouse TG neurons. <bold>(A)</bold> Representative immunolocalization of p35 (green) and &#x003b2;III-tubulin (red) from TG neurons treated with TNF-&#x003b1; alone or with roscovitine. Scale bars are 50 &#x003bc;m. <bold>(B)</bold> Quantification of p35 fluorescence intensity of images in <bold>(A)</bold>. <bold>(C)</bold> Representative images of Nox1, NOXO1, Nox2, and p47<sup>phox</sup> endogenous expression in TG neurons treated with TNF-&#x003b1; alone or with roscovitine. Scale bars are 10 &#x003bc;m. <bold>(D&#x02013;G)</bold> Quantification of Nox1 <bold>(D)</bold>, NOXO1 <bold>(E)</bold>, Nox2 <bold>(F)</bold>, and p47<sup>phox</sup>
<bold>(G)</bold> fluorescence intensity in TG neurons of images in <bold>(C)</bold>. The bar graphs represent mean &#x000b1; <italic>SD</italic>. Statistical differences correspond to a one-way ANOVA with a Bonferroni's multiple comparison test. Number of analyzed neurons is inside each corresponding bar.</p></caption><graphic xlink:href="fphys-09-00065-g0005"/></fig></sec><sec><title>TNF-&#x003b1; increased NOXO1 translocation to plasma membrane in primary culture of mouse TG neurons</title><p>Our results showed a significantly increased NOX-dependent ROS production in nociceptive neurons directed by TNF-&#x003b1; signaling and in part by Cdk5 activation. However, an important aspect in NOX complex activation is the recruitment of cytoplasmic subunits to plasma membrane (Debbabi et al., <xref rid="B12" ref-type="bibr">2013</xref>). Therefore, we analyzed the plasma membrane translocation (Figures <xref ref-type="fig" rid="F6">6A,B</xref>) of cytoplasmic subunits NOXO1 and p47<sup>phox</sup> after TNF-&#x003b1; treatment by using confocal images (Figure <xref ref-type="fig" rid="F5">5C</xref>). These analyses revealed that NOXO1 translocation to plasma membrane was enhanced upon TNF-&#x003b1; treatment (Figure <xref ref-type="fig" rid="F6">6C</xref>). In contrast, we did not find a clear change in its distribution toward peripheral regions for p47<sup>phox</sup> (Figure <xref ref-type="fig" rid="F6">6D</xref>). Interestingly, roscovitine treatment reverted TNF-&#x003b1; effect on NOXO1 plasma membrane translocation (Figures <xref ref-type="fig" rid="F6">6B,C</xref>), which suggests a role of Cdk5 in the recruitment of NOXO1 to peripheral compartments in primary cultured nociceptive neurons.</p><fig id="F6" position="float"><label>Figure 6</label><caption><p>TNF-&#x003b1; increases NOXO1 translocation to plasma membrane in primary culture of mouse TG neurons. <bold>(A)</bold> Upper panel: Descriptive sketch for measurement of plasma membrane translocation of cytosolic NOX subunits. Line represents the measurement of plasma membrane protein translocation indicating a peripheral area (blue section) followed for a centric area (red section). Lower panel: Descriptive plot profile showing measurement of cytosolic NOX along 2D neuron surface. <bold>(B)</bold> Representative immunofluorescences of NOXO1 (white/green) and &#x003b2;III-tubulin (red) from TG neurons treated with TNF-&#x003b1; (50 ng/ml) alone or with roscovitine (20 mM) during 24 h. Scale bars are 20 &#x003bc;m. <bold>(C,D)</bold> Measurement of NOXO1 <bold>(B)</bold> and p47<sup>phox</sup>
<bold>(D)</bold> translocation to plasma membrane in 2DIV primary culture of TG neurons treated with TNF-&#x003b1; alone or with roscovitine. Plasma membrane translocation was measured from fluorescence intensity into plasma membrane (peripheral area) of TG neurons, normalized against fluorescence intensity in the cytosolic compartment (centric area). The bar graphs represent mean &#x000b1; <italic>SD</italic>. Statistical differences correspond to a one-way ANOVA with a Bonferroni's multiple comparison test. Number of analyzed neurons is inside each corresponding bar.</p></caption><graphic xlink:href="fphys-09-00065-g0006"/></fig></sec></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>In the present work we established for the first time an association between Cdk5 activation and ROS production directed by NOX1 and NOX2 complexes suggesting an important role during inflammatory pain (Figure <xref ref-type="fig" rid="F7">7</xref>). First, in HEK293 cells transfected with p35, a heterologous expression system, the activation of Cdk5 promotes hydrogen peroxide production that was reverted by pharmacological inhibition of NOX complex or by inhibition of Cdk5 activity. Second, in primary culture of mouse nociceptive neurons, an endogenous expression system, TNF-&#x003b1; treatment increased ROS production and this effect was reverted by inhibition of Cdk5 or NOX complex. Third, TNF-&#x003b1; treatment increased the expression of catalytic (Nox1 and Nox2) and cytosolic (NOXO1 and p47<sup>phox</sup>) members of NOX1 and NOX2 complexes in TG neurons. Moreover, TNF-&#x003b1; treatment induced NOXO1 plasma membrane translocation and roscovitine blocked this effect. Altogether these results demonstrate that Cdk5 contributes to ROS production mediated by NOX1 and NOX2 activation and suggest its involvement during inflammatory pain.</p><fig id="F7" position="float"><label>Figure 7</label><caption><p>Proposed mechanism for ROS production in nociceptive neurons exposed to TNF-&#x003b1;. Under an inflammatory state, primary sensory neurons are exposed to a pro-inflammatory cytokines soup. TNF-&#x003b1; binds to TNF-&#x003b1; receptor and triggers the MAPK/ERK1/2 pathway. ERK1/2 translocate to nucleus promoting the expression of the transcription factor Early growth response protein 1 (Egr1) which consecutively binds to the p35 promoter causing an increase of p35 protein expression. Activation of Cdk5 by p35 leads to phosphorylation of diverse substrates located in nociceptive neurons; we suggest that this event favors NOX complex association and consequently increases ROS production in these neurons. As ROS represent signaling molecules in pain hypersensitivity, we speculate that this redox imbalance could modify functions of other proteins involved in signal transmission of nociceptive neurons.</p></caption><graphic xlink:href="fphys-09-00065-g0007"/></fig><p>Few years ago, our group established the participation of Cdk5 in pain signaling (Pareek et al., <xref rid="B47" ref-type="bibr">2006</xref>; Utreras et al., <xref rid="B53" ref-type="bibr">2009a</xref>) principally after initiation of an inflammatory response (Utreras et al., <xref rid="B54" ref-type="bibr">2009b</xref>, <xref rid="B58" ref-type="bibr">2011</xref>, <xref rid="B55" ref-type="bibr">2012</xref>; Rozas et al., <xref rid="B49" ref-type="bibr">2016</xref>). In particular, Cdk5 phosphorylates many substrates important in pain such as TRPV1 (Pareek et al., <xref rid="B46" ref-type="bibr">2007</xref>; Jendryke et al., <xref rid="B24" ref-type="bibr">2016</xref>; Rozas et al., <xref rid="B49" ref-type="bibr">2016</xref>), P2X2aR (Coddou et al., <xref rid="B10" ref-type="bibr">2017</xref>), KIF13B (Xing et al., <xref rid="B63" ref-type="bibr">2012</xref>), delta opioid receptors (Xie et al., <xref rid="B62" ref-type="bibr">2009</xref>), among others. Cdk5 phosphorylates TRPV1 in Thr407 decreasing its activation threshold (Jendryke et al., <xref rid="B24" ref-type="bibr">2016</xref>; Rozas et al., <xref rid="B49" ref-type="bibr">2016</xref>). Similarly, Cdk5 phosphorylates purinergic receptor P2X2aR in Thr372 slowing desensitization of the channel (Coddou et al., <xref rid="B10" ref-type="bibr">2017</xref>). Interestingly, both TRPV1 and P2X2aR are ion channels related with hypersensitization during inflammatory pain (Linley et al., <xref rid="B40" ref-type="bibr">2010</xref>). On the other hand, ROS molecules play an important role during inflammatory and neuropathic pain (Kallenborn-Gerhardt et al., <xref rid="B27" ref-type="bibr">2013</xref>), however, the link between ROS production and Cdk5 activation has not yet been addressed until now.</p><p>Our results showed that direct activation of Cdk5 by p35 overexpression significantly increased intracellular ROS production in HEK293 cells. Since VAS2870 treatment significantly decreases this redox imbalance, NOX complex raises as a good candidate of ROS source in HEK293 cells. Several members of NOX1 and NOX2 complexes were immunodetected in HEK293 cells, which supports the participation of these enzymes in ROS production mediated by Cdk5 activation. In addition, we detected a NOX-dependent basal production of hydrogen peroxide by HyPer sensor in these cells, because NOX inhibition with VAS2870 significantly decreased ROS production in untransfected cells. Since VAS2870 treatment did not revert Cdk5-mediated ROS levels totally, it could be explained by the activation of other sources of ROS induced by p35 overexpression. In addition, ROS production was not completely abolished in HEK293 cells transfected with p35 and treated with roscovitine, probably because Cdk5 activation by p35 overexpression overcomes the inhibition capacity of roscovitine and a fraction of Cdk5 remained active. Interestingly, this effect was not observed in primary culture of TG neurons where p35 levels were considerably smaller as compared with our heterologous expression system. Moreover, higher concentration of roscovitine could generate a toxic effect on the cells or favor non-specific inhibition of other biological pathways (Bach et al., <xref rid="B1" ref-type="bibr">2005</xref>; Li et al., <xref rid="B36" ref-type="bibr">2008</xref>).</p><p>We reported earlier that overexpression of TNF-&#x003b1; in nociceptive neurons increases p35 expression and Cdk5 activity, with a subsequent TRPV1 phosphorylation and an increment in pain signaling (Rozas et al., <xref rid="B49" ref-type="bibr">2016</xref>). Here, we evaluated whether increased Cdk5 activity mediated by TNF-&#x003b1; enhances ROS production in nociceptive neurons. Our results showed that TNF-&#x003b1; treatment significantly increased ROS production in DRG and TG neurons approximately in 50% as compared with control neurons. Similar to HEK293 cells, both roscovitine and VAS2870 treatment reverted ROS production induced by TNF-&#x003b1;, which supports a molecular link between Cdk5 and NOX complexes function, and establishes a potential contribution of Cdk5 activation in the redox balance of nociceptive neurons. Most important, participation of NOX complexes in pain signaling has been already reported (Ibi et al., <xref rid="B21" ref-type="bibr">2008</xref>; Kim et al., <xref rid="B30" ref-type="bibr">2010</xref>; Im et al., <xref rid="B23" ref-type="bibr">2012b</xref>; Kallenborn-Gerhardt et al., <xref rid="B26" ref-type="bibr">2012</xref>; Lim et al., <xref rid="B37" ref-type="bibr">2013</xref>; Kallenborn-Gerhardt et al., <xref rid="B25" ref-type="bibr">2014</xref>). However, only few reports are linked to pro-inflammatory activation (Ibi et al., <xref rid="B21" ref-type="bibr">2008</xref>; Lim et al., <xref rid="B37" ref-type="bibr">2013</xref>). On the other hand, there is evidence that pro-inflammatory cytokines like TNF-&#x003b1; modulate NOX-dependent ROS production in different types of cells (Chen et al., <xref rid="B9" ref-type="bibr">2008</xref>; Lin et al., <xref rid="B38" ref-type="bibr">2015a</xref>; Blaser et al., <xref rid="B6" ref-type="bibr">2016</xref>) including neurons (Barth et al., <xref rid="B3" ref-type="bibr">2009</xref>, <xref rid="B2" ref-type="bibr">2012</xref>; Kuhn, <xref rid="B32" ref-type="bibr">2014</xref>). In addition, interleukin 1&#x003b2; and interleukin 6 have been involved in ROS production mediated by NOX enzymes in different cellular models (So et al., <xref rid="B51" ref-type="bibr">2007</xref>; Kim et al., <xref rid="B30" ref-type="bibr">2010</xref>; Pang et al., <xref rid="B45" ref-type="bibr">2012</xref>; Kuhn, <xref rid="B32" ref-type="bibr">2014</xref>). Our data suggests that increased ROS production mediated by TNF-&#x003b1; treatment could be explained by a higher expression of NOX1 and NOX2 members in nociceptive neurons similarly to previous reports (Kim et al., <xref rid="B31" ref-type="bibr">2007</xref>, <xref rid="B30" ref-type="bibr">2010</xref>; Blaser et al., <xref rid="B6" ref-type="bibr">2016</xref>). However, NOX4 represents an important source of ROS in DRG neurons contributing to pain hypersensitization (Im et al., <xref rid="B22" ref-type="bibr">2012a</xref>; Kallenborn-Gerhardt et al., <xref rid="B26" ref-type="bibr">2012</xref>; Ding et al., <xref rid="B15" ref-type="bibr">2017</xref>), moreover regulating TRPV1 activity (Lin et al., <xref rid="B39" ref-type="bibr">2015b</xref>; Ding et al., <xref rid="B14" ref-type="bibr">2016</xref>). Therefore, this study cannot exclude the possibility that NOX4 participates in Cdk5-mediated ROS production.</p><p>NOX cytosolic members NOXO1 and p47<sup>phox</sup> can undergo post-translational modification by phosphorylation dependent of PKC (Fontayne et al., <xref rid="B17" ref-type="bibr">2002</xref>; Debbabi et al., <xref rid="B12" ref-type="bibr">2013</xref>) inducing NOX activation and ROS production. Interestingly, we found a minimal consensus sequence (Ser/Thr-Pro) for Cdk5 phosphorylation in mouse p47<sup>phox</sup> protein (Ser215 and Thr356) and a full consensus sequence for Cdk5 (Ser/Thr(Pro)X(Lis/His/Arg) (B&#x000f3;rquez et al., <xref rid="B7" ref-type="bibr">2013</xref>) in NOXO1 protein (Ser3). Therefore, we postulate that Cdk5 upon activation could phosphorylate cytosolic subunits of NOX1 and NOX2, promoting activation and ROS production, although further experiments are needed to demonstrate such a novel regulation.</p><p>Considering this scenario, we think that Cdk5-mediated ROS production in nociceptive neurons could contribute to enhancing pain signaling by an additional mechanism. Interestingly, several receptors expressed on the surface of TG and DRG neurons are susceptible to activity modulation by cysteine oxidation, such as TRPV1, transient receptor potential ankyrin 1 (TRPA1), N-methyl-d-aspartate (NMDA) receptors, and T-type Ca<sup>2+</sup> channels, among others (Gamper and Ooi, <xref rid="B18" ref-type="bibr">2015</xref>). However additional experiments are needed to demonstrate the real impact of Cdk5-mediated ROS production in the nociceptive circuitry including the central nervous system. In summary, taken together our results suggest that Cdk5 activation may be implicated in the ROS production by NOX1 and NOX2 complexes during inflammatory pain and this relationship could address additional roles to Cdk5 in pain signaling.</p></sec><sec id="s5"><title>Author contributions</title><p>RS, CG-B, and EU designed the project. RS, PL, FF, NP, and EU performed the experiments. RS, PL, FF, CG-B, and EU analyzed the data. RS, CG-B, and EU wrote the manuscript. EU supervised the experiments and finalized the manuscript.</p><sec><title>Conflict of interest statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>We would like to thank Pablo Jimenez and Mat&#x000ed;as Lira for technical assistance and Carlos Wilson for his technical recommendations. The authors have no conflicts of interest to declare. This work was supported by FONDECYT 1151043 (to EU) and FONDECYT 1140325 and FONDAP 15150012 (to CG-B).</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bach</surname><given-names>S.</given-names></name><name><surname>Knockaert</surname><given-names>M.</given-names></name><name><surname>Reinhardt</surname><given-names>J.</given-names></name><name><surname>Lozach</surname><given-names>O.</given-names></name><name><surname>Schmitt</surname><given-names>S.</given-names></name><name><surname>Baratte</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Roscovitine targets, protein kinases and pyridoxal kinase</article-title>. <source>J. Biol. Chem.</source>
<volume>280</volume>, <fpage>31208</fpage>&#x02013;<lpage>31219</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M500806200</pub-id><?supplied-pmid 15975926?><pub-id pub-id-type="pmid">15975926</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barth</surname><given-names>B. M.</given-names></name><name><surname>Gustafson</surname><given-names>S. J.</given-names></name><name><surname>Kuhn</surname><given-names>T. B.</given-names></name></person-group> (<year>2012</year>). <article-title>Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-alpha</article-title>. <source>J. Neurosci. Res.</source>
<volume>90</volume>, <fpage>229</fpage>&#x02013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.22748</pub-id><?supplied-pmid 21932365?><pub-id pub-id-type="pmid">21932365</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barth</surname><given-names>B. M.</given-names></name><name><surname>Stewart-Smeets</surname><given-names>S.</given-names></name><name><surname>Kuhn</surname><given-names>T. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Proinflammatory cytokines provoke oxidative damage to actin in neuronal cells mediated by Rac1 and NADPH oxidase</article-title>. <source>Mol. Cell. Neurosci.</source>
<volume>41</volume>, <fpage>274</fpage>&#x02013;<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2009.03.007</pub-id><?supplied-pmid 19344766?><pub-id pub-id-type="pmid">19344766</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basbaum</surname><given-names>A. I.</given-names></name><name><surname>Bautista</surname><given-names>D. M.</given-names></name><name><surname>Scherrer</surname><given-names>G.</given-names></name><name><surname>Julius</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Cellular and molecular mechanisms of pain</article-title>. <source>Cell</source>
<volume>139</volume>, <fpage>267</fpage>&#x02013;<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.09.028</pub-id><?supplied-pmid 19837031?><pub-id pub-id-type="pmid">19837031</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belousov</surname><given-names>V. V.</given-names></name><name><surname>Fradkov</surname><given-names>A. F.</given-names></name><name><surname>Lukyanov</surname><given-names>K. A.</given-names></name><name><surname>Staroverov</surname><given-names>D. B.</given-names></name><name><surname>Shakhbazov</surname><given-names>K. S.</given-names></name><name><surname>Terskikh</surname><given-names>A. V.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Genetically encoded fluorescent indicator for intracellular hydrogen peroxide</article-title>. <source>Nat. Methods</source>
<volume>3</volume>, <fpage>281</fpage>&#x02013;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth866</pub-id><?supplied-pmid 16554833?><pub-id pub-id-type="pmid">16554833</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaser</surname><given-names>H.</given-names></name><name><surname>Dostert</surname><given-names>C.</given-names></name><name><surname>Mak</surname><given-names>T. W.</given-names></name><name><surname>Brenner</surname><given-names>D.</given-names></name></person-group> (<year>2016</year>). <article-title>TNF and ROS crosstalk in inflammation</article-title>. <source>Trends Cell Biol.</source>
<volume>26</volume>, <fpage>249</fpage>&#x02013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2015.12.002</pub-id><?supplied-pmid 26791157?><pub-id pub-id-type="pmid">26791157</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f3;rquez</surname><given-names>D. A.</given-names></name><name><surname>Olmos</surname><given-names>C.</given-names></name><name><surname>&#x000c1;lvarez</surname><given-names>S.</given-names></name><name><surname>Di Genova</surname><given-names>A.</given-names></name><name><surname>Maass</surname><given-names>A.</given-names></name><name><surname>Gonz&#x000e1;lez-Billault</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>Bioinformatic survey for new physiological substrates of Cyclin-dependent kinase 5</article-title>. <source>Genomics</source>
<volume>101</volume>, <fpage>221</fpage>&#x02013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2013.01.003</pub-id><?supplied-pmid 23384938?><pub-id pub-id-type="pmid">23384938</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f3;rquez</surname><given-names>D. A.</given-names></name><name><surname>Urrutia</surname><given-names>P. J.</given-names></name><name><surname>Wilson</surname><given-names>C.</given-names></name><name><surname>van Zundert</surname><given-names>B.</given-names></name><name><surname>Nunez</surname><given-names>M. T.</given-names></name><name><surname>Gonzalez-Billault</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>Dissecting the role of redox signaling in neuronal development</article-title>. <source>J. Neurochem.</source>
<volume>137</volume>, <fpage>506</fpage>&#x02013;<lpage>517</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13581</pub-id><?supplied-pmid 26875993?><pub-id pub-id-type="pmid">26875993</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Andresen</surname><given-names>B. T.</given-names></name><name><surname>Hill</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Booth</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction</article-title>. <source>Curr. Hypertens. Rev.</source>
<volume>4</volume>, <fpage>245</fpage>&#x02013;<lpage>255</lpage>. <pub-id pub-id-type="doi">10.2174/157340208786241336</pub-id><?supplied-pmid 20559453?><pub-id pub-id-type="pmid">20559453</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coddou</surname><given-names>C.</given-names></name><name><surname>Sandoval</surname><given-names>R.</given-names></name><name><surname>Castro</surname><given-names>P.</given-names></name><name><surname>Lazcano</surname><given-names>P.</given-names></name><name><surname>Hevia</surname><given-names>M. J.</given-names></name><name><surname>Rokic</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Cyclin-dependent kinase 5 modulates the P2X2a receptor channel gating through phosphorylation of C-terminal threonine 372</article-title>. <source>Pain</source>
<volume>158</volume>, <fpage>2155</fpage>&#x02013;<lpage>2168</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000001021</pub-id><?supplied-pmid 28809765?><pub-id pub-id-type="pmid">28809765</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contreras-Vallejos</surname><given-names>E.</given-names></name><name><surname>Utreras</surname><given-names>E.</given-names></name><name><surname>Gonzalez-Billault</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Going out of the brain: non-nervous system physiological and pathological functions of Cdk5</article-title>. <source>Cell. Signal.</source>
<volume>24</volume>, <fpage>44</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2011.08.022</pub-id><?supplied-pmid 21924349?><pub-id pub-id-type="pmid">21924349</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debbabi</surname><given-names>M.</given-names></name><name><surname>Kroviarski</surname><given-names>Y.</given-names></name><name><surname>Bournier</surname><given-names>O.</given-names></name><name><surname>Gougerot-Pocidalo</surname><given-names>M. A.</given-names></name><name><surname>El-Benna</surname><given-names>J.</given-names></name><name><surname>Dang</surname><given-names>P. M.</given-names></name></person-group> (<year>2013</year>). <article-title>NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1 assembly and activation</article-title>. <source>FASEB J.</source>
<volume>27</volume>, <fpage>1733</fpage>&#x02013;<lpage>1748</lpage>. <pub-id pub-id-type="doi">10.1096/fj.12-216432</pub-id><?supplied-pmid 23322165?><pub-id pub-id-type="pmid">23322165</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhariwala</surname><given-names>F. A.</given-names></name><name><surname>Rajadhyaksha</surname><given-names>M. S.</given-names></name></person-group> (<year>2008</year>). <article-title>An unusual member of the Cdk family: Cdk5</article-title>. <source>Cell. Mol. Neurobiol.</source>
<volume>28</volume>, <fpage>351</fpage>&#x02013;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-007-9242-1</pub-id><?supplied-pmid 18183483?><pub-id pub-id-type="pmid">18183483</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>R.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Zhu</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Advanced oxidation protein products sensitized the transient receptor potential vanilloid 1 via NADPH oxidase 1 and 4 to cause mechanical hyperalgesia</article-title>. <source>Redox Biol.</source>
<volume>10</volume>, <fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2016.09.004</pub-id><?supplied-pmid 27665186?><pub-id pub-id-type="pmid">27665186</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>R.</given-names></name><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Yao</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Advanced oxidative protein products cause pain hypersensitivity in rats by inducing dorsal root ganglion neurons apoptosis via NADPH oxidase 4/c-Jun N-terminal kinase pathways</article-title>. <source>Front. Mol. Neurosci.</source>
<volume>10</volume>:<fpage>195</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2017.00195</pub-id><?supplied-pmid 28674486?><pub-id pub-id-type="pmid">28674486</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Benna</surname><given-names>J.</given-names></name><name><surname>Dang</surname><given-names>P. M.</given-names></name><name><surname>Gougerot-Pocidalo</surname><given-names>M. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane</article-title>. <source>Semin. Immunopathol.</source>
<volume>30</volume>, <fpage>279</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1007/s00281-008-0118-3</pub-id><?supplied-pmid 18536919?><pub-id pub-id-type="pmid">18536919</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontayne</surname><given-names>A.</given-names></name><name><surname>Dang</surname><given-names>P. M.</given-names></name><name><surname>Gougerot-Pocidalo</surname><given-names>M. A.</given-names></name><name><surname>El-Benna</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Phosphorylation of p47phox sites by PKC alpha, beta II, delta, and zeta: effect on binding to p22phox and on NADPH oxidase activation</article-title>. <source>Biochemistry</source>
<volume>41</volume>, <fpage>7743</fpage>&#x02013;<lpage>7750</lpage>. <pub-id pub-id-type="doi">10.1021/bi011953s</pub-id><?supplied-pmid 12056906?><pub-id pub-id-type="pmid">12056906</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N.</given-names></name><name><surname>Ooi</surname><given-names>L.</given-names></name></person-group> (<year>2015</year>). <article-title>Redox and nitric oxide-mediated regulation of sensory neuron ion channel function</article-title>. <source>Antioxid. Redox Signal</source>
<volume>22</volume>, <fpage>486</fpage>&#x02013;<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2014.5884</pub-id><?supplied-pmid 24735331?><pub-id pub-id-type="pmid">24735331</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geis</surname><given-names>C.</given-names></name><name><surname>Geuss</surname><given-names>E.</given-names></name><name><surname>Sommer</surname><given-names>C.</given-names></name><name><surname>Schmidt</surname><given-names>H. H.</given-names></name><name><surname>Kleinschnitz</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>NOX4 is an early initiator of neuropathic pain</article-title>. <source>Exp. Neurol.</source>
<volume>288</volume>, <fpage>94</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2016.11.008</pub-id><?supplied-pmid 27856286?><pub-id pub-id-type="pmid">27856286</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holmstr&#x000f6;m</surname><given-names>K. M.</given-names></name><name><surname>Finkel</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Cellular mechanisms and physiological consequences of redox-dependent signalling</article-title>. <source>Nat. Rev. Mol. Cell Biol.</source>
<volume>15</volume>, <fpage>411</fpage>&#x02013;<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3801</pub-id><?supplied-pmid 24854789?><pub-id pub-id-type="pmid">24854789</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibi</surname><given-names>M.</given-names></name><name><surname>Matsuno</surname><given-names>K.</given-names></name><name><surname>Shiba</surname><given-names>D.</given-names></name><name><surname>Katsuyama</surname><given-names>M.</given-names></name><name><surname>Iwata</surname><given-names>K.</given-names></name><name><surname>Kakehi</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Reactive oxygen species derived from NOX1/NADPH oxidase enhance inflammatory pain</article-title>. <source>J. Neurosci.</source>
<volume>28</volume>, <fpage>9486</fpage>&#x02013;<lpage>9494</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1857-08.2008</pub-id><?supplied-pmid 18799680?><pub-id pub-id-type="pmid">18799680</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>Y. B.</given-names></name><name><surname>Jee</surname><given-names>M. K.</given-names></name><name><surname>Choi</surname><given-names>J. I.</given-names></name><name><surname>Cho</surname><given-names>H. T.</given-names></name><name><surname>Kwon</surname><given-names>O. H.</given-names></name><name><surname>Kang</surname><given-names>S. K.</given-names></name></person-group> (<year>2012a</year>). <article-title>Molecular targeting of NOX4 for neuropathic pain after traumatic injury of the spinal cord</article-title>. <source>Cell Death Dis.</source>
<volume>3</volume>, <fpage>e426</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2012.168</pub-id><?supplied-pmid 23152062?><pub-id pub-id-type="pmid">23152062</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>Y. B.</given-names></name><name><surname>Jee</surname><given-names>M. K.</given-names></name><name><surname>Jung</surname><given-names>J. S.</given-names></name><name><surname>Choi</surname><given-names>J. I.</given-names></name><name><surname>Jang</surname><given-names>J. H.</given-names></name><name><surname>Kang</surname><given-names>S. K.</given-names></name></person-group> (<year>2012b</year>). <article-title>miR23b ameliorates neuropathic pain in spinal cord by silencing NADPH oxidase 4</article-title>. <source>Antioxid. Redox Signal.</source>
<volume>16</volume>, <fpage>1046</fpage>&#x02013;<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2011.4224</pub-id><?supplied-pmid 22149086?><pub-id pub-id-type="pmid">22149086</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jendryke</surname><given-names>T.</given-names></name><name><surname>Prochazkova</surname><given-names>M.</given-names></name><name><surname>Hall</surname><given-names>B. E.</given-names></name><name><surname>Nordmann</surname><given-names>G. C.</given-names></name><name><surname>Schladt</surname><given-names>M.</given-names></name><name><surname>Milenkovic</surname><given-names>V. M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>TRPV1 function is modulated by Cdk5-mediated phosphorylation: insights into the molecular mechanism of nociception</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>:<fpage>22007</fpage>. <pub-id pub-id-type="doi">10.1038/srep22007</pub-id><?supplied-pmid 26902776?><pub-id pub-id-type="pmid">26902776</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallenborn-Gerhardt</surname><given-names>W.</given-names></name><name><surname>Hohmann</surname><given-names>S. W.</given-names></name><name><surname>Syhr</surname><given-names>K. M.</given-names></name><name><surname>Schr&#x000f6;der</surname><given-names>K.</given-names></name><name><surname>Sisignano</surname><given-names>M.</given-names></name><name><surname>Weigert</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Nox2-dependent signaling between macrophages and sensory neurons contributes to neuropathic pain hypersensitivity</article-title>. <source>Pain</source>
<volume>155</volume>, <fpage>2161</fpage>&#x02013;<lpage>2170</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2014.08.013</pub-id><?supplied-pmid 25139590?><pub-id pub-id-type="pmid">25139590</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallenborn-Gerhardt</surname><given-names>W.</given-names></name><name><surname>Schr&#x000f6;der</surname><given-names>K.</given-names></name><name><surname>Del Turco</surname><given-names>D.</given-names></name><name><surname>Lu</surname><given-names>R.</given-names></name><name><surname>Kynast</surname><given-names>K.</given-names></name><name><surname>Kosowski</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>NADPH oxidase-4 maintains neuropathic pain after peripheral nerve injury</article-title>. <source>J. Neurosci.</source>
<volume>32</volume>, <fpage>10136</fpage>&#x02013;<lpage>10145</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6227-11.2012</pub-id><?supplied-pmid 22836249?><pub-id pub-id-type="pmid">22836249</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kallenborn-Gerhardt</surname><given-names>W.</given-names></name><name><surname>Schr&#x000f6;der</surname><given-names>K.</given-names></name><name><surname>Geisslinger</surname><given-names>G.</given-names></name><name><surname>Schmidtko</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>NOXious signaling in pain processing</article-title>. <source>Pharmacol. Ther.</source>
<volume>137</volume>, <fpage>309</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2012.11.001</pub-id><?supplied-pmid 23146925?><pub-id pub-id-type="pmid">23146925</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>A. A.</given-names></name><name><surname>Diogenes</surname><given-names>A.</given-names></name><name><surname>Jeske</surname><given-names>N. A.</given-names></name><name><surname>Henry</surname><given-names>M. A.</given-names></name><name><surname>Akopian</surname><given-names>A.</given-names></name><name><surname>Hargreaves</surname><given-names>K. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Tumor necrosis factor alpha enhances the sensitivity of rat trigeminal neurons to capsaicin</article-title>. <source>Neuroscience</source>
<volume>155</volume>, <fpage>503</fpage>&#x02013;<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.05.036</pub-id><?supplied-pmid 18582539?><pub-id pub-id-type="pmid">18582539</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khattab</surname><given-names>M. M.</given-names></name></person-group> (<year>2006</year>). <article-title>TEMPOL, a membrane-permeable radical scavenger, attenuates peroxynitrite- and superoxide anion-enhanced carrageenan-induced paw edema and hyperalgesia: a key role for superoxide anion</article-title>. <source>Eur. J. Pharmacol.</source>
<volume>548</volume>, <fpage>167</fpage>&#x02013;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2006.08.007</pub-id><?supplied-pmid 16973155?><pub-id pub-id-type="pmid">16973155</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>S. J.</given-names></name><name><surname>Oh</surname><given-names>G. S.</given-names></name><name><surname>Moon</surname><given-names>H. D.</given-names></name><name><surname>Kwon</surname><given-names>K. B.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity</article-title>. <source>J. Neurosci.</source>
<volume>30</volume>, <fpage>3933</fpage>&#x02013;<lpage>3946</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6054-09.2010</pub-id><?supplied-pmid 20237264?><pub-id pub-id-type="pmid">20237264</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y. S.</given-names></name><name><surname>Morgan</surname><given-names>M. J.</given-names></name><name><surname>Choksi</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>Z. G.</given-names></name></person-group> (<year>2007</year>). <article-title>TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death</article-title>. <source>Mol. Cell</source>
<volume>26</volume>, <fpage>675</fpage>&#x02013;<lpage>687</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2007.04.021</pub-id><?supplied-pmid 17560373?><pub-id pub-id-type="pmid">17560373</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>T. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Oxygen radicals elicit paralysis and collapse of spinal cord neuron growth cones upon exposure to proinflammatory cytokines</article-title>. <source>Biomed Res. Int.</source>
<volume>2014</volume>:<fpage>191767</fpage>. <pub-id pub-id-type="doi">10.1155/2014/191767</pub-id><?supplied-pmid 25050325?><pub-id pub-id-type="pmid">25050325</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauro</surname><given-names>F.</given-names></name><name><surname>Ilari</surname><given-names>S.</given-names></name><name><surname>Giancotti</surname><given-names>L. A.</given-names></name><name><surname>Ventura</surname><given-names>C. A.</given-names></name><name><surname>Morabito</surname><given-names>C.</given-names></name><name><surname>Gliozzi</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Pharmacological effect of a new idebenone formulation in a model of carrageenan-induced inflammatory pain</article-title>. <source>Pharmacol. Res.</source>
<volume>111</volume>, <fpage>767</fpage>&#x02013;<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2016.07.043</pub-id><?supplied-pmid 27480201?><pub-id pub-id-type="pmid">27480201</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebel</surname><given-names>C. P.</given-names></name><name><surname>Bondy</surname><given-names>S. C.</given-names></name></person-group> (<year>1990</year>). <article-title>Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes</article-title>. <source>Neurochem. Int.</source>
<volume>17</volume>, <fpage>435</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1016/0197-0186(90)90025-O</pub-id><?supplied-pmid 20504643?><pub-id pub-id-type="pmid">20504643</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lew</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>Q. Q.</given-names></name><name><surname>Qi</surname><given-names>Z.</given-names></name><name><surname>Winkfein</surname><given-names>R. J.</given-names></name><name><surname>Aebersold</surname><given-names>R.</given-names></name><name><surname>Hunt</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>1994</year>). <article-title>A brain-specific activator of cyclin-dependent kinase 5</article-title>. <source>Nature</source>
<volume>371</volume>, <fpage>423</fpage>&#x02013;<lpage>426</lpage>. <pub-id pub-id-type="doi">10.1038/371423a0</pub-id><?supplied-pmid 8090222?><pub-id pub-id-type="pmid">8090222</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>A. Y.</given-names></name><name><surname>Han</surname><given-names>M.</given-names></name><name><surname>Zheng</surname><given-names>B.</given-names></name><name><surname>Wen</surname><given-names>J. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Roscovitine inhibits ERK1/2 activation induced by angiotensin II in vascular smooth muscle cells</article-title>. <source>FEBS Lett.</source>
<volume>582</volume>, <fpage>243</fpage>&#x02013;<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1016/j.febslet.2007.12.011</pub-id><?supplied-pmid 18083124?><pub-id pub-id-type="pmid">18083124</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>S. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Toll-like receptor 2 mediates peripheral nerve injury-induced NADPH oxidase 2 expression in spinal cord microglia</article-title>. <source>J. Biol. Chem.</source>
<volume>288</volume>, <fpage>7572</fpage>&#x02013;<lpage>7579</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.414904</pub-id><?supplied-pmid 23386616?><pub-id pub-id-type="pmid">23386616</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C. C.</given-names></name><name><surname>Yang</surname><given-names>C. C.</given-names></name><name><surname>Wang</surname><given-names>C. Y.</given-names></name><name><surname>Tseng</surname><given-names>H. C.</given-names></name><name><surname>Pan</surname><given-names>C. S.</given-names></name><name><surname>Hsiao</surname><given-names>L. D.</given-names></name><etal/></person-group>. (<year>2015a</year>). <article-title>NADPH oxidase/ROS-dependent VCAM-1 induction on TNF-alpha-challenged human cardiac fibroblasts enhances monocyte adhesion</article-title>. <source>Front. Pharmacol.</source>
<volume>6</volume>:<fpage>310</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2015.00310</pub-id><?supplied-pmid 26858641?><pub-id pub-id-type="pmid">26858641</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>C. S.</given-names></name><name><surname>Lee</surname><given-names>S. H.</given-names></name><name><surname>Huang</surname><given-names>H. S.</given-names></name><name><surname>Chen</surname><given-names>Y. S.</given-names></name><name><surname>Ma</surname><given-names>M. C.</given-names></name></person-group> (<year>2015b</year>). <article-title>H2O2 generated by NADPH oxidase 4 contributes to transient receptor potential vanilloid 1 channel-mediated mechanosensation in the rat kidney</article-title>. <source>Am. J. Physiol. Renal Physiol.</source>
<volume>309</volume>, <fpage>F369</fpage>&#x02013;<lpage>F376</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00462.2014</pub-id><?supplied-pmid 26136558?><pub-id pub-id-type="pmid">26136558</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linley</surname><given-names>J. E.</given-names></name><name><surname>Rose</surname><given-names>K.</given-names></name><name><surname>Ooi</surname><given-names>L.</given-names></name><name><surname>Gamper</surname><given-names>N.</given-names></name></person-group> (<year>2010</year>). <article-title>Understanding inflammatory pain: ion channels contributing to acute and chronic nociception</article-title>. <source>Pflugers Arch.</source>
<volume>459</volume>, <fpage>657</fpage>&#x02013;<lpage>669</lpage>. <pub-id pub-id-type="doi">10.1007/s00424-010-0784-6</pub-id><?supplied-pmid 20162302?><pub-id pub-id-type="pmid">20162302</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukyanov</surname><given-names>K. A.</given-names></name><name><surname>Belousov</surname><given-names>V. V.</given-names></name></person-group> (<year>2014</year>). <article-title>Genetically encoded fluorescent redox sensors</article-title>. <source>Biochim. Biophys. Acta</source>
<volume>1840</volume>, <fpage>745</fpage>&#x02013;<lpage>756</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2013.05.030</pub-id><?supplied-pmid 23726987?><pub-id pub-id-type="pmid">23726987</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCloy</surname><given-names>R. A.</given-names></name><name><surname>Rogers</surname><given-names>S.</given-names></name><name><surname>Caldon</surname><given-names>C. E.</given-names></name><name><surname>Lorca</surname><given-names>T.</given-names></name><name><surname>Castro</surname><given-names>A.</given-names></name><name><surname>Burgess</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events</article-title>. <source>Cell Cycle</source>
<volume>13</volume>, <fpage>1400</fpage>&#x02013;<lpage>1412</lpage>. <pub-id pub-id-type="doi">10.4161/cc.28401</pub-id><?supplied-pmid 24626186?><pub-id pub-id-type="pmid">24626186</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijles</surname><given-names>D. N.</given-names></name><name><surname>Fan</surname><given-names>L. M.</given-names></name><name><surname>Howlin</surname><given-names>B. J.</given-names></name><name><surname>Li</surname><given-names>J. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Molecular insights of p47phox phosphorylation dynamics in the regulation of NADPH oxidase activation and superoxide production</article-title>. <source>J. Biol. Chem.</source>
<volume>289</volume>, <fpage>22759</fpage>&#x02013;<lpage>22770</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.561159</pub-id><?supplied-pmid 24970888?><pub-id pub-id-type="pmid">24970888</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname><given-names>M.</given-names></name><name><surname>Siddiqui</surname><given-names>M. R.</given-names></name><name><surname>Tran</surname><given-names>K.</given-names></name><name><surname>Reddy</surname><given-names>S. P.</given-names></name><name><surname>Malik</surname><given-names>A. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Reactive oxygen species in inflammation and tissue injury</article-title>. <source>Antioxid. Redox Signal.</source>
<volume>20</volume>, <fpage>1126</fpage>&#x02013;<lpage>1167</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2012.5149</pub-id><?supplied-pmid 23991888?><pub-id pub-id-type="pmid">23991888</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Benicky</surname><given-names>J.</given-names></name><name><surname>S&#x000e1;nchez-Lemus</surname><given-names>E.</given-names></name><name><surname>Saavedra</surname><given-names>J. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Telmisartan directly ameliorates the neuronal inflammatory response to IL-1beta partly through the JNK/c-Jun and NADPH oxidase pathways</article-title>. <source>J. Neuroinflammation</source>
<volume>9</volume>:<fpage>102</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-102</pub-id><?supplied-pmid 22642771?><pub-id pub-id-type="pmid">22642771</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pareek</surname><given-names>T. K.</given-names></name><name><surname>Keller</surname><given-names>J.</given-names></name><name><surname>Kesavapany</surname><given-names>S.</given-names></name><name><surname>Agarwal</surname><given-names>N.</given-names></name><name><surname>Kuner</surname><given-names>R.</given-names></name><name><surname>Pant</surname><given-names>H. C.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>104</volume>, <fpage>660</fpage>&#x02013;<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0609916104</pub-id><?supplied-pmid 17194758?><pub-id pub-id-type="pmid">17194758</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pareek</surname><given-names>T. K.</given-names></name><name><surname>Keller</surname><given-names>J.</given-names></name><name><surname>Kesavapany</surname><given-names>S.</given-names></name><name><surname>Pant</surname><given-names>H. C.</given-names></name><name><surname>Iadarola</surname><given-names>M. J.</given-names></name><name><surname>Brady</surname><given-names>R. O.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Cyclin-dependent kinase 5 activity regulates pain signaling</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source>
<volume>103</volume>, <fpage>791</fpage>&#x02013;<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0510405103</pub-id><?supplied-pmid 16407116?><pub-id pub-id-type="pmid">16407116</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prochazkova</surname><given-names>M.</given-names></name><name><surname>Terse</surname><given-names>A.</given-names></name><name><surname>Amin</surname><given-names>N. D.</given-names></name><name><surname>Hall</surname><given-names>B.</given-names></name><name><surname>Utreras</surname><given-names>E.</given-names></name><name><surname>Pant</surname><given-names>H. C.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia</article-title>. <source>Mol. Pain</source>
<volume>9</volume>:<fpage>66</fpage>. <pub-id pub-id-type="doi">10.1186/1744-8069-9-66</pub-id><?supplied-pmid 24359609?><pub-id pub-id-type="pmid">24359609</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozas</surname><given-names>P.</given-names></name><name><surname>Lazcano</surname><given-names>P.</given-names></name><name><surname>Pina</surname><given-names>R.</given-names></name><name><surname>Cho</surname><given-names>A.</given-names></name><name><surname>Terse</surname><given-names>A.</given-names></name><name><surname>Pertusa</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Targeted overexpression of tumor necrosis factor-alpha increases cyclin-dependent kinase 5 activity and TRPV1-dependent Ca<sup>2+</sup> influx in trigeminal neurons</article-title>. <source>Pain</source>
<volume>157</volume>, <fpage>1346</fpage>&#x02013;<lpage>1362</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000527</pub-id><?supplied-pmid 26894912?><pub-id pub-id-type="pmid">26894912</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sessle</surname><given-names>B. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Peripheral and central mechanisms of orofacial inflammatory pain</article-title>. <source>Int. Rev. Neurobiol.</source>
<volume>97</volume>, <fpage>179</fpage>&#x02013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-385198-7.00007-2</pub-id><?supplied-pmid 21708311?><pub-id pub-id-type="pmid">21708311</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>So</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Park</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Kim</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB</article-title>. <source>J. Assoc. Res. Otolaryngol.</source>
<volume>8</volume>, <fpage>338</fpage>&#x02013;<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1007/s10162-007-0084-9</pub-id><?supplied-pmid 17516123?><pub-id pub-id-type="pmid">17516123</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumimoto</surname><given-names>H.</given-names></name><name><surname>Miyano</surname><given-names>K.</given-names></name><name><surname>Takeya</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>Molecular composition and regulation of the Nox family NAD(P)H oxidases</article-title>. <source>Biochem. Biophys. Res. Commun.</source>
<volume>338</volume>, <fpage>677</fpage>&#x02013;<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2005.08.210</pub-id><?supplied-pmid 16157295?><pub-id pub-id-type="pmid">16157295</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utreras</surname><given-names>E.</given-names></name><name><surname>Futatsugi</surname><given-names>A.</given-names></name><name><surname>Pareek</surname><given-names>T. K.</given-names></name><name><surname>Kulkarni</surname><given-names>A. B.</given-names></name></person-group> (<year>2009a</year>). <article-title>Molecular roles of Cdk5 in pain signaling</article-title>. <source>Drug Discov. Today Ther. Strateg.</source>
<volume>6</volume>, <fpage>105</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.ddstr.2009.04.004</pub-id><?supplied-pmid 21253436?><pub-id pub-id-type="pmid">21253436</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utreras</surname><given-names>E.</given-names></name><name><surname>Futatsugi</surname><given-names>A.</given-names></name><name><surname>Rudrabhatla</surname><given-names>P.</given-names></name><name><surname>Keller</surname><given-names>J.</given-names></name><name><surname>Iadarola</surname><given-names>M. J.</given-names></name><name><surname>Pant</surname><given-names>H. C.</given-names></name><etal/></person-group>. (<year>2009b</year>). <article-title>Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35</article-title>. <source>J. Biol. Chem.</source>
<volume>284</volume>, <fpage>2275</fpage>&#x02013;<lpage>2284</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M805052200</pub-id><?supplied-pmid 19049962?><pub-id pub-id-type="pmid">19049962</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utreras</surname><given-names>E.</given-names></name><name><surname>Keller</surname><given-names>J.</given-names></name><name><surname>Terse</surname><given-names>A.</given-names></name><name><surname>Prochazkova</surname><given-names>M.</given-names></name><name><surname>Iadarola</surname><given-names>M. J.</given-names></name><name><surname>Kulkarni</surname><given-names>A. B.</given-names></name></person-group> (<year>2012</year>). <article-title>Transforming growth factor-beta1 regulates Cdk5 activity in primary sensory neurons</article-title>. <source>J. Biol. Chem.</source>
<volume>287</volume>, <fpage>16917</fpage>&#x02013;<lpage>16929</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.329979</pub-id><?supplied-pmid 22451679?><pub-id pub-id-type="pmid">22451679</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utreras</surname><given-names>E.</given-names></name><name><surname>Maccioni</surname><given-names>R.</given-names></name><name><surname>Gonz&#x000e1;lez-Billault</surname><given-names>C.</given-names></name></person-group> (<year>2009c</year>). <article-title>Cyclin-dependent kinase 5 activator p35 over-expression and amyloid beta synergism increase apoptosis in cultured neuronal cells</article-title>. <source>Neuroscience</source>
<volume>161</volume>, <fpage>978</fpage>&#x02013;<lpage>987</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.04.002</pub-id><?supplied-pmid 19362124?><pub-id pub-id-type="pmid">19362124</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utreras</surname><given-names>E.</given-names></name><name><surname>Prochazkova</surname><given-names>M.</given-names></name><name><surname>Terse</surname><given-names>A.</given-names></name><name><surname>Gross</surname><given-names>J.</given-names></name><name><surname>Keller</surname><given-names>J.</given-names></name><name><surname>Iadarola</surname><given-names>M. J.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>TGF-beta1 sensitizes TRPV1 through Cdk5 signaling in odontoblast-like cells</article-title>. <source>Mol. Pain</source>
<volume>9</volume>:<fpage>24</fpage>. <pub-id pub-id-type="doi">10.1186/1744-8069-9-24</pub-id><?supplied-pmid 23668392?><pub-id pub-id-type="pmid">23668392</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utreras</surname><given-names>E.</given-names></name><name><surname>Terse</surname><given-names>A.</given-names></name><name><surname>Keller</surname><given-names>J.</given-names></name><name><surname>Iadarola</surname><given-names>M. J.</given-names></name><name><surname>Kulkarni</surname><given-names>A. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Resveratrol inhibits Cdk5 activity through regulation of p35 expression</article-title>. <source>Mol. Pain</source>
<volume>7</volume>:<fpage>49</fpage>. <pub-id pub-id-type="doi">10.1186/1744-8069-7-49</pub-id><?supplied-pmid 21736731?><pub-id pub-id-type="pmid">21736731</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>C.</given-names></name><name><surname>Mu&#x000f1;oz-Palma</surname><given-names>E.</given-names></name><name><surname>Gonz&#x000e1;lez-Billault</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>From birth to death: a role for reactive oxygen species in neuronal development</article-title>. <source>Semin. Cell Dev. Biol</source>. <volume>17</volume>, <fpage>30334</fpage>&#x02013;<lpage>30338</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2017.09.012</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>C.</given-names></name><name><surname>N&#x000fa;&#x000f1;ez</surname><given-names>M. T.</given-names></name><name><surname>Gonz&#x000e1;lez-Billault</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Contribution of NADPH oxidase to the establishment of hippocampal neuronal polarity in culture</article-title>. <source>J. Cell Sci.</source>
<volume>128</volume>, <fpage>2989</fpage>&#x02013;<lpage>2995</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.168567</pub-id><?supplied-pmid 26101350?><pub-id pub-id-type="pmid">26101350</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>P. C.</given-names></name><name><surname>Hsiao</surname><given-names>H. T.</given-names></name><name><surname>Lin</surname><given-names>Y. C.</given-names></name><name><surname>Shieh</surname><given-names>D. B.</given-names></name><name><surname>Liu</surname><given-names>Y. C.</given-names></name></person-group> (<year>2017</year>). <article-title>The analgesia efficiency of ultrasmall magnetic iron oxide nanoparticles in mice chronic inflammatory pain model</article-title>. <source>Nanomedicine</source>
<volume>13</volume>, <fpage>1975</fpage>&#x02013;<lpage>1981</lpage>. <pub-id pub-id-type="doi">10.1016/j.nano.2017.05.005</pub-id><?supplied-pmid 28539274?><pub-id pub-id-type="pmid">28539274</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>W. Y.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>Y. R.</given-names></name><name><surname>Li</surname><given-names>Y. F.</given-names></name><name><surname>Kang</surname><given-names>K.</given-names></name><name><surname>Xing</surname><given-names>B. M.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Disruption of Cdk5-associated phosphorylation of residue threonine-161 of the delta-opioid receptor: impaired receptor function and attenuated morphine antinociceptive tolerance</article-title>. <source>J. Neurosci.</source>
<volume>29</volume>, <fpage>3551</fpage>&#x02013;<lpage>3564</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0415-09.2009</pub-id><?supplied-pmid 19295160?><pub-id pub-id-type="pmid">19295160</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>B. M.</given-names></name><name><surname>Yang</surname><given-names>Y. R.</given-names></name><name><surname>Du</surname><given-names>J. X.</given-names></name><name><surname>Chen</surname><given-names>H. J.</given-names></name><name><surname>Qi</surname><given-names>C.</given-names></name><name><surname>Huang</surname><given-names>Z. H.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Cyclin-dependent kinase 5 controls TRPV1 membrane trafficking and the heat sensitivity of nociceptors through KIF13B</article-title>. <source>J. Neurosci.</source>
<volume>32</volume>, <fpage>14709</fpage>&#x02013;<lpage>14721</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1634-12.2012</pub-id><?supplied-pmid 23077056?><pub-id pub-id-type="pmid">23077056</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>Y. L.</given-names></name><name><surname>Li</surname><given-names>B. S.</given-names></name><name><surname>Amin</surname><given-names>N. D.</given-names></name><name><surname>Albers</surname><given-names>W.</given-names></name><name><surname>Pant</surname><given-names>H. C.</given-names></name></person-group> (<year>2002</year>). <article-title>A peptide derived from cyclin-dependent kinase activator (p35) specifically inhibits Cdk5 activity and phosphorylation of tau protein in transfected cells</article-title>. <source>Eur. J. Biochem.</source>
<volume>269</volume>, <fpage>4427</fpage>&#x02013;<lpage>4434</lpage>. <pub-id pub-id-type="doi">10.1046/j.1432-1033.2002.03133.x</pub-id><?supplied-pmid 12230554?><pub-id pub-id-type="pmid">12230554</pub-id></mixed-citation></ref></ref-list></back></article>